Pasithea Therapeutics (KTTA) Depreciation and Depletion (2022 - 2024)
Historic Depreciation and Depletion for Pasithea Therapeutics (KTTA) over the last 3 years, with Q4 2024 value amounting to $4717.0.
- Pasithea Therapeutics' Depreciation and Depletion rose 79.06% to $4717.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $19150.0, marking a year-over-year increase of 470.2%. This contributed to the annual value of $18865.0 for FY2024, which is 314.38% up from last year.
- Latest data reveals that Pasithea Therapeutics reported Depreciation and Depletion of $4717.0 as of Q4 2024, which was up 79.06% from $4716.0 recorded in Q3 2024.
- In the past 5 years, Pasithea Therapeutics' Depreciation and Depletion registered a high of $5014.0 during Q1 2022, and its lowest value of -$4057.0 during Q2 2022.
- Its 3-year average for Depreciation and Depletion is $3544.5, with a median of $4715.5 in 2023.
- Within the past 5 years, the most significant YoY rise in Pasithea Therapeutics' Depreciation and Depletion was 47160000.0% (2023), while the steepest drop was 1665.34% (2023).
- Quarter analysis of 3 years shows Pasithea Therapeutics' Depreciation and Depletion stood at $4138.0 in 2022, then increased by 13.1% to $4680.0 in 2023, then increased by 0.79% to $4717.0 in 2024.
- Its Depreciation and Depletion was $4717.0 in Q4 2024, compared to $4716.0 in Q3 2024 and $5000.0 in Q2 2024.